Brian Schoenbaum

Experience the NEXT EVOLUTION OF FUN. The Gel Blaster SURGE, electronic gel blaster, brings battle back to the backyard. With just enough sting to make it exciting, the Gel Blaster SURGE provides 4-5 hours of active and adrenaline pumping fun. Want to play Gel Blaster in a glow-in-the-dark arena? Gel Blaster Nexus™ combines the best elements of paintball, laser tag and video games into thrilling team battles! It’s like playing a real world video game - find out more at gelblaster.com/nexus.

Next Generation Anti-Infectives that Mimic Natural Human Antimicrobial Peptides Maxwell Biosciences is a preclinical stage drug platform company partnering with large pharma companies to develop an entirely new class of patented low molecular weight drug candidates that destroy SARS-CoV-2, the COVID virus, as well as other viruses and infectious pathogens (including fungal and bacterial pathogens). Maxwells first-in-class CLAROMER™ brand drug discovery platform mimics natural human immune system antimicrobial and antiviral peptides. Maxwell Biosciences has benefitted from over $35M of non-dilutive grants and awards from governments around the world to validate their science and technology, including studies by US Govt-funded labs confirming that Maxwells lead drug candidate has direct virucidal action against Herpes virus (HSV-1) and SARS-CoV-2, the COVID virus. Additionally, live mouse safety data at Texas A&M show Maxwells drugs benefit from a tissue-safe toxicology profiles, and live mouse studies from the Baylor College of Medicine show breakthrough fungicidal action with CLAROMER™ brand compounds against lethal fungal infections of the upper-respiratory tract. These findings support the expected safety and effectiveness of Maxwells “multi-asset, multi-target” anti-infectives drug platform. Maxwells drug platform is supported by a granted patent portfolio and is strongly positioned in the fight against emergent viral pandemics and a broad spectrum of evolving infectious pathogens. Maxwell is raising funds for advanced preclinical and human trials.

Pre-seed. Stealth.

Neighborhood grocery store featuring a full service deli and coffee bar. Highly curated selections of the highest quality products and grocery staples. Located in the heart of South Congress in Austin TX.

Experience the NEXT EVOLUTION OF FUN. The Gel Blaster SURGE, electronic gel blaster, brings battle back to the backyard. With just enough sting to make it exciting, the Gel Blaster SURGE provides 4-5 hours of active and adrenaline pumping fun. Want to play Gel Blaster in a glow-in-the-dark arena? Gel Blaster Nexus™ combines the best elements of paintball, laser tag and video games into thrilling team battles! It’s like playing a real world video game - find out more at gelblaster.com/nexus.

Next Generation Anti-Infectives that Mimic Natural Human Antimicrobial Peptides Maxwell Biosciences is a preclinical stage drug platform company partnering with large pharma companies to develop an entirely new class of patented low molecular weight drug candidates that destroy SARS-CoV-2, the COVID virus, as well as other viruses and infectious pathogens (including fungal and bacterial pathogens). Maxwells first-in-class CLAROMER™ brand drug discovery platform mimics natural human immune system antimicrobial and antiviral peptides. Maxwell Biosciences has benefitted from over $35M of non-dilutive grants and awards from governments around the world to validate their science and technology, including studies by US Govt-funded labs confirming that Maxwells lead drug candidate has direct virucidal action against Herpes virus (HSV-1) and SARS-CoV-2, the COVID virus. Additionally, live mouse safety data at Texas A&M show Maxwells drugs benefit from a tissue-safe toxicology profiles, and live mouse studies from the Baylor College of Medicine show breakthrough fungicidal action with CLAROMER™ brand compounds against lethal fungal infections of the upper-respiratory tract. These findings support the expected safety and effectiveness of Maxwells “multi-asset, multi-target” anti-infectives drug platform. Maxwells drug platform is supported by a granted patent portfolio and is strongly positioned in the fight against emergent viral pandemics and a broad spectrum of evolving infectious pathogens. Maxwell is raising funds for advanced preclinical and human trials.

Pre-seed. Stealth.

Neighborhood grocery store featuring a full service deli and coffee bar. Highly curated selections of the highest quality products and grocery staples. Located in the heart of South Congress in Austin TX.